Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

It has been over a year since people with multiple sclerosis (pwMS) have been receiving vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a negligible number of cases in which vaccination led to a relapse or new onset MS, experts around the world agree that the pote...

Full description

Bibliographic Details
Main Authors: Maura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, Carlo Pozzilli, Laura Airas, Mona Alkhawajah, Nikolaos Grigoriadis, Melinda Magyari, Bart Van Wijmeersch, Magd Zakaria, Ralf Linker, Andrew Chan, Patrick Vermersch, Thomas Berger
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
COVID-19
vaccines
SARS-CoV-2
multiple sclerosis
disease modifying therapies
immune response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1045101/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1045101/full

Similar Items